Geode Capital Management’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.54M Buy
114,816
+7,040
+7% +$401K ﹤0.01% 2593
2025
Q1
$6.04M Buy
107,776
+9,839
+10% +$552K ﹤0.01% 2569
2024
Q4
$6.02M Buy
97,937
+857
+0.9% +$52.7K ﹤0.01% 2652
2024
Q3
$6.5M Buy
97,080
+8,516
+10% +$570K ﹤0.01% 2618
2024
Q2
$5.92M Buy
88,564
+14,885
+20% +$995K ﹤0.01% 2630
2024
Q1
$5.24M Buy
73,679
+1,659
+2% +$118K ﹤0.01% 2677
2023
Q4
$6.07M Buy
72,020
+3,296
+5% +$278K ﹤0.01% 2606
2023
Q3
$5.91M Buy
68,724
+2,396
+4% +$206K ﹤0.01% 2562
2023
Q2
$6.18M Sell
66,328
-5,083
-7% -$474K ﹤0.01% 2577
2023
Q1
$6.77M Buy
71,411
+1,085
+2% +$103K ﹤0.01% 2490
2022
Q4
$7.07M Buy
70,326
+547
+0.8% +$55K ﹤0.01% 2473
2022
Q3
$5.95M Buy
69,779
+1,715
+3% +$146K ﹤0.01% 2578
2022
Q2
$5.85M Buy
68,064
+9,216
+16% +$792K ﹤0.01% 2617
2022
Q1
$5.29M Buy
58,848
+2,082
+4% +$187K ﹤0.01% 2768
2021
Q4
$5.68M Buy
56,766
+588
+1% +$58.8K ﹤0.01% 2831
2021
Q3
$5.22M Sell
56,178
-451
-0.8% -$41.9K ﹤0.01% 2891
2021
Q2
$4.82M Buy
56,629
+2,707
+5% +$230K ﹤0.01% 2934
2021
Q1
$4.67M Buy
53,922
+793
+1% +$68.7K ﹤0.01% 2824
2020
Q4
$4.48M Buy
53,129
+81
+0.2% +$6.83K ﹤0.01% 2661
2020
Q3
$4.24M Buy
53,048
+682
+1% +$54.5K ﹤0.01% 2492
2020
Q2
$4.64M Buy
52,366
+819
+2% +$72.6K ﹤0.01% 2381
2020
Q1
$4.85M Buy
51,547
+1,662
+3% +$156K ﹤0.01% 2167
2019
Q4
$5.38M Sell
49,885
-507
-1% -$54.7K ﹤0.01% 2408
2019
Q3
$4.83M Sell
50,392
-1,974
-4% -$189K ﹤0.01% 2400
2019
Q2
$5.01M Buy
52,366
+116
+0.2% +$11.1K ﹤0.01% 2391
2019
Q1
$4.61M Buy
52,250
+2,543
+5% +$224K ﹤0.01% 2385
2018
Q4
$4.13M Buy
49,707
+1,422
+3% +$118K ﹤0.01% 2329
2018
Q3
$4.55M Buy
48,285
+2,273
+5% +$214K ﹤0.01% 2409
2018
Q2
$5.07M Buy
46,012
+3,247
+8% +$358K ﹤0.01% 2312
2018
Q1
$4.23M Sell
42,765
-6,419
-13% -$634K ﹤0.01% 2343
2017
Q4
$4M Buy
49,184
+3,849
+8% +$313K ﹤0.01% 2333
2017
Q3
$3.33M Buy
45,335
+3,118
+7% +$229K ﹤0.01% 2447
2017
Q2
$3.06M Buy
42,217
+4,740
+13% +$343K ﹤0.01% 2476
2017
Q1
$2.33M Buy
37,477
+1,550
+4% +$96.5K ﹤0.01% 2579
2016
Q4
$2.61M Buy
35,927
+597
+2% +$43.4K ﹤0.01% 2475
2016
Q3
$2.11M Sell
35,330
-86
-0.2% -$5.14K ﹤0.01% 2527
2016
Q2
$2.23M Buy
35,416
+570
+2% +$35.9K ﹤0.01% 2404
2016
Q1
$2.18K Buy
34,846
+4,815
+16% +$301 ﹤0.01% 2397
2015
Q4
$1.76M Buy
30,031
+365
+1% +$21.4K ﹤0.01% 2564
2015
Q3
$1.6M Buy
29,666
+759
+3% +$40.9K ﹤0.01% 2583
2015
Q2
$1.72M Buy
28,907
+254
+0.9% +$15.1K ﹤0.01% 2598
2015
Q1
$1.72M Buy
28,653
+14,976
+109% +$896K ﹤0.01% 2539
2014
Q4
$821K Buy
13,677
+473
+4% +$28.4K ﹤0.01% 2952
2014
Q3
$643K Buy
13,204
+412
+3% +$20.1K ﹤0.01% 3044
2014
Q2
$658K Buy
12,792
+1,372
+12% +$70.6K ﹤0.01% 3034
2014
Q1
$660K Buy
11,420
+2,703
+31% +$156K ﹤0.01% 3013
2013
Q4
$498K Buy
8,717
+1,295
+17% +$74K ﹤0.01% 3092
2013
Q3
$441K Buy
7,422
+476
+7% +$28.3K ﹤0.01% 3010
2013
Q2
$377K Buy
+6,946
New +$377K ﹤0.01% 3002